Fat tissue drug delivery system for cancer treatment
Summary
USPTO published patent application US20260090990A1 for a fat tissue-based drug delivery system designed for cancer treatment. The invention comprises fat tissue or derivatives thereof for delivering molecules, preferably antitumor drugs. The application (No. 19307845) was filed August 22, 2025, with inventors including Augusto Pessina, Giulio Alessandri, Carlo Tremolada, and Offer Zeira.
What changed
USPTO published patent application US20260090990A1 claiming a drug delivery system comprising fat tissue or derivatives thereof for administering therapeutic molecules. The system is specifically directed toward delivering antitumor agents for cancer treatment. The application classifies under CPC codes A61K 9/148, A61K 45/06, and A61K 47/46.
This is a published patent application, not a regulatory requirement. No compliance actions, deadlines, or penalties are associated with this filing. Pharmaceutical companies, drug manufacturers, and healthcare researchers developing fat-based delivery systems or cancer treatments may wish to review this application to assess potential freedom-to-operate considerations or licensing opportunities.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
DRUG DELIVERY SYSTEM
Application US20260090990A1 Kind: A1 Apr 02, 2026
Inventors
Augusto PESSINA, Giulio ALESSANDRI, Carlo Ferdinando Maria TREMOLADA, Offer ZEIRA
Abstract
The present invention refers to a delivery system for molecules, preferably drugs, said system comprising fat tissue or derivatives thereof. Moreover, the present invention refers to a fat-based delivery system, preferably loaded with molecules having antitumor activities, for use in the treatment of cancers.
CPC Classifications
A61K 9/148 A61K 45/06 A61K 47/46
Filing Date
2025-08-22
Application No.
19307845
Related changes
Get daily alerts for ChangeBridge: Patent Apps - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: Patent Apps - Pharma (A61K) publishes new changes.